`571-272-7822
`
`
`
` Paper 21
`
`Entered: February 7, 2014
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`APOTEX CORP.
`Petitioner
`
`
`
`
`
`v.
`
`ALCON RESEARCH, LTD
`Patent Owner.
`____________
`
`Cases IPR2013-00428 (Patent 8,268,299 B2)
`IPR2013-00429 (Patent 8,323,630 B2)
`IPR2013-00430 (Patent 8,388,941 B2) 1
`
`____________
`
`Before LORA M. GREEN, FRANCISCO C. PRATS, and RAMA G. ELLURU,
`Administrative Patent Judges.
`
`GREEN, Administrative Patent Judge.
`
`
`
`DECISION
`Apotex Corp.’s Motion for Pro Hac Vice Admission of
`Paul A. Ainsworth
`37 C.F.R. § 42.10
`
`
`
`
`1 This order addresses issues that are the same in all three cases. We exercise our
`discretion to issue one order to be filed in each case. The parties, however, are not
`authorized to use this style heading in subsequent papers.
`
`
`
`Cases IPR2013-00428 (Patent 8,268,299 B2)
`IPR2013-00429 (Patent 8,323,630 B2)
`IPR2013-00430 (Patent 8,388,941 B2)
`
`
`Petitioner, Apotex Corp., (“Apotex”), filed a Motion for Pro Hac Vice
`
`Admission of Paul A. Ainsworth Under 37 C.F.R. § 42.10(c) (Papers 16, 14, and
`
`15),2 accompanied by an Affidavit of Mr. Ainsworth in support of the Motion (Ex.
`
`1017 in each proceeding). At the initial conference held on February 3, 2014,
`
`Patent Owner indicated that it had no objection to the Motion. For the reasons
`
`provided below, Apotex’s Motion is granted.
`
`
`
`As set forth in 37 C.F.R. § 42.10(c), the Board may recognize counsel pro
`
`hac vice during a proceeding upon a showing of good cause, subject to the
`
`condition that lead counsel be a registered practitioner. For example, where the
`
`lead counsel is a registered practitioner, a non-registered practitioner may be
`
`permitted to appear pro hac vice “upon showing that counsel is an experienced
`
`litigating attorney and has an established familiarity with the subject matter at issue
`
`in the proceeding.” 37 C.F.R. § 42.10(c). In authorizing motions for pro hac vice
`
`admission, the Board also requires a statement of facts showing there is good cause
`
`for the Board to recognize counsel pro hac vice and an affidavit or declaration of
`
`the individual seeking to appear in this proceeding. See Paper 4 in each
`
`proceeding (referencing the “Order – Authorizing Motion for Pro Hac Vice
`
`Admission,” Paper 6 in IPR2013-00010).
`
`
`
`In its Motion, Apotex asserts that there is good cause for Mr. Ainsworth’s
`
`pro hac vice admission because: (1) Mr. Ainsworth is an experienced patent
`
`litigation attorney, and (2) Mr. Ainsworth has an established familiarity with the
`
`subject matter at issue in the instant proceedings as he has engaged in hours of
`
`
`2 All references to the papers refer to the three proceedings in numerical order; i.e.,
`the first paper number refers to the paper number in IPR2013-00428, the second
`paper number refers to the paper number in IPR2013-00429, and the third paper
`number refers to the paper number in IPR2013-00430.
`
`
`
`2
`
`
`
`Cases IPR2013-00428 (Patent 8,268,299 B2)
`IPR2013-00429 (Patent 8,323,630 B2)
`IPR2013-00430 (Patent 8,388,941 B2)
`
`strategic and substantive discussions regarding the proceedings with lead counsel
`
`for Petitioner in the proceedings, is familiar with ophthalmic compositions such as
`
`those covered in the ’299, ’630 and ’941 patents through previous litigation
`
`involving similar ophthalmic compositions, and has served as trial counsel for
`
`Petitioner in district court litigation concerning patents directed to ophthalmic drug
`
`formulations and methods of use. (Papers 16, 14, and 15 at 5-7). In support of the
`
`Motion, Mr. Ainsworth attests to these facts in his Affidavit with sufficient
`
`explanations. Ex. 1017. Moreover, Apotex’s lead counsel, Eldora L. Ellison, is a
`
`registered practitioner. (Papers 16, 14, and 15 at 3).
`
`Based on the facts set forth above, we conclude that Mr. Ainsworth has
`
`sufficient legal and technical qualifications to represent Apotex in this proceeding
`
`and that there is a need for Apotex to have its trial counsel involved in these
`
`proceedings. See IPR2013-00639, Paper 7, dated October 15, 2013 (superseding
`
`IPR2013-00010, Paper 6, dated October 15, 2012, and setting forth the
`
`requirements for pro hac vice admission) (copy available on the Board Web site
`
`under “Representative Orders, Decisions, and Notices”). Accordingly, Apotex has
`
`established good cause for Mr. Ainsworth’s pro hac vice admission. Mr.
`
`Ainsworth will be permitted to appear pro hac vice in the instant proceeding as
`
`back-up counsel only. See 37 C.F.R. § 42.10(c).
`
`
`
`
`
`For the foregoing reasons, it is
`
`ORDERED that Apotex’s Motion for Pro Hac Vice Admission of
`
`Mr. Ainsworth for the instant proceeding is granted; Mr. Ainsworth is authorized
`
`to represent Apotex as back-up counsel in the instant proceedings;
`
`
`
`FURTHER ORDERED that Apotex is to continue to have a registered
`
`practitioner as lead counsel in the instant proceedings;
`
`
`
`3
`
`
`
`Cases IPR2013-00428 (Patent 8,268,299 B2)
`IPR2013-00429 (Patent 8,323,630 B2)
`IPR2013-00430 (Patent 8,388,941 B2)
`
`
`
`FURTHER ORDRED that Mr. Ainsworth is to comply with the Office
`
`Patent Trial Practice Guide and the Board’s Rules of Practice for Trials, as set forth
`
`in Title 37, Part 42 of the Code of Federal Regulations; and
`
`
`
`FURTHER ORDERED that Mr. Ainsworth is to be subject to the Office’s
`
`disciplinary jurisdiction under 37 C.F.R. § 11.19(a), and the USPTO Rules of
`
`Professional Conduct set forth in 37 C.F.R. §§ 11.101 et. seq.
`
`
`For PETITIONER:
`Eldora L. Ellison
`Ralph W. Powers, III
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`(202) 371-2600
`eellison-PTAB@skgf.com
`tpowers-PTAB@skgf.com
`
`For PATENT OWNER:
`Stanley E. Fisher
`WILLIAMS & CONNOLLY LLP
`(202) 434-5289
`sfisher@wc.com
`
`
`
`
`4
`
`